Rafael A. Rodriguez, a director of Neogen Corp, filed a statement of changes in beneficial ownership on October 30, 2026, reporting the vesting and settlement of restricted stock units on October 29, 2026.

Key Highlights

  • Reporting person: Rafael A. Rodriguez, identified as a director of Neogen Corp (NASDAQ:NEOG).
  • Transaction: 1,776 restricted stock units (RSUs) vested and were settled into an equal number of shares of common stock on October 29, 2026.
  • Transaction code: M (conversion or exercise of a derivative security), recorded at a price of $12.21 per share.
  • Resulting ownership: Following the transaction, Rodriguez directly holds 31,211 shares of Neogen common stock.
  • Derivative position: Rodriguez's RSU balance stands at 0 following the settlement, according to the filing.
  • Filed by: Christopher Sefcheck, identified as attorney in fact, signed the filing on October 30, 2026.

RSU Vesting Details for Neogen Director Rafael A. Rodriguez

According to the filing, Rodriguez's 1,776 RSUs were converted into an equal number of common shares on October 29, 2026. The filing's explanation of responses states: "Each RSU is the economic equivalent of one share of common stock. On October 29, 2026, these RSUs vested and were settled for an equal number of shares of common stock." The transaction is recorded under code M, which corresponds to the conversion or exercise of a derivative security.

Neogen Corp, headquartered in Lansing, Michigan, is listed on NASDAQ under the ticker NEOG. The company operates in the food and animal safety sector, providing diagnostic products and services. Rodriguez's direct beneficial ownership of Neogen common stock increased to 31,211 shares following the RSU settlement, while his RSU balance was reduced to zero, as reported in Table II of the filing. The filing was submitted by Christopher Sefcheck as attorney in fact on October 30, 2026.

What Was Disclosed

The filing reported the October 29, 2026 vesting and settlement of 1,776 RSUs held by Neogen director Rafael A. Rodriguez into an equal number of common shares at $12.21, bringing his direct holdings to 31,211 shares of Neogen common stock.